HK1004373A1 - Use of penciclovir for the treatment of human herpes-virus-8 - Google Patents

Use of penciclovir for the treatment of human herpes-virus-8

Info

Publication number
HK1004373A1
HK1004373A1 HK98103679A HK98103679A HK1004373A1 HK 1004373 A1 HK1004373 A1 HK 1004373A1 HK 98103679 A HK98103679 A HK 98103679A HK 98103679 A HK98103679 A HK 98103679A HK 1004373 A1 HK1004373 A1 HK 1004373A1
Authority
HK
Hong Kong
Prior art keywords
treatment
penciclovir
virus
human herpes
bioprecursor
Prior art date
Application number
HK98103679A
Other languages
English (en)
Inventor
Klaus Max Esser
Richard Anthony Vere Hodge
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of HK1004373A1 publication Critical patent/HK1004373A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Transplantation (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK98103679A 1995-03-07 1998-04-29 Use of penciclovir for the treatment of human herpes-virus-8 HK1004373A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504497.0A GB9504497D0 (en) 1995-03-07 1995-03-07 Pharmaceuticals
PCT/EP1996/000933 WO1996027378A2 (en) 1995-03-07 1996-03-05 Use of penciclovir for the treatment of human herpes-virus-8

Publications (1)

Publication Number Publication Date
HK1004373A1 true HK1004373A1 (en) 1998-11-27

Family

ID=10770731

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98103679A HK1004373A1 (en) 1995-03-07 1998-04-29 Use of penciclovir for the treatment of human herpes-virus-8

Country Status (23)

Country Link
US (1) US6489330B1 (da)
EP (1) EP0814813B1 (da)
JP (2) JPH11501625A (da)
KR (1) KR19980702833A (da)
CN (1) CN1138545C (da)
AT (1) ATE254919T1 (da)
AU (1) AU701739B2 (da)
BR (1) BR9607663A (da)
CA (1) CA2214406C (da)
CY (1) CY2525B1 (da)
CZ (1) CZ293470B6 (da)
DE (1) DE69630876T2 (da)
DK (1) DK0814813T3 (da)
ES (1) ES2211949T3 (da)
GB (1) GB9504497D0 (da)
HK (1) HK1004373A1 (da)
HU (1) HU226005B1 (da)
NO (1) NO317733B1 (da)
NZ (1) NZ303951A (da)
PT (1) PT814813E (da)
TR (1) TR199700921T1 (da)
WO (1) WO1996027378A2 (da)
ZA (1) ZA961795B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009002893A (es) 2006-09-18 2009-07-10 Raptor Pharmaceutical Inc Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap).
CA2721148A1 (en) * 2008-04-11 2009-10-15 Epiphany Biosciences, Inc. Treatment and/or prevention of multiple sclerosis
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (de) * 1983-08-18 1991-12-05 Beecham Group Plc Antivirale guanin-derivate.
DE3582399D1 (de) * 1984-09-20 1991-05-08 Beecham Group Plc Purin-derivate und ihre pharmazeutische verwendung.
EP0216459B1 (en) * 1985-07-27 1990-05-16 Beecham Group Plc 9-substituted guanine monohydrates
CA2042931A1 (en) 1990-05-24 1991-11-25 Robert Zahler Fluorinated bis (hydroxymethyl) cyclobutyl purines and pyrimidines
GB9015051D0 (en) 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment

Also Published As

Publication number Publication date
PT814813E (pt) 2004-04-30
HUP9800272A3 (en) 2000-12-28
DE69630876T2 (de) 2004-09-02
ES2211949T3 (es) 2004-07-16
CA2214406C (en) 2010-12-21
HUP9800272A2 (hu) 2000-05-28
EP0814813B1 (en) 2003-11-26
EP0814813A2 (en) 1998-01-07
JP2007297412A (ja) 2007-11-15
NZ303951A (en) 1999-07-29
CY2525B1 (en) 2006-02-08
NO317733B1 (no) 2004-12-13
TR199700921T1 (xx) 1998-02-21
CZ283197A3 (cs) 1998-02-18
KR19980702833A (ko) 1998-08-05
HU226005B1 (en) 2008-02-28
GB9504497D0 (en) 1995-04-26
CZ293470B6 (cs) 2004-05-12
MX9706759A (es) 1997-11-29
WO1996027378A2 (en) 1996-09-12
DE69630876D1 (de) 2004-01-08
US6489330B1 (en) 2002-12-03
BR9607663A (pt) 1998-06-16
DK0814813T3 (da) 2004-03-22
WO1996027378A3 (en) 1997-01-16
AU5102296A (en) 1996-09-23
JPH11501625A (ja) 1999-02-09
ZA961795B (en) 1996-11-25
AU701739B2 (en) 1999-02-04
ATE254919T1 (de) 2003-12-15
NO974101D0 (no) 1997-09-05
CA2214406A1 (en) 1996-09-12
CN1183722A (zh) 1998-06-03
NO974101L (no) 1997-09-05
CN1138545C (zh) 2004-02-18

Similar Documents

Publication Publication Date Title
CY2525B1 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9108629D0 (en) Heterocyclic pharmaceutical compounds,preparation and use
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
DE69429447D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 7 infektionen
IL111138A (en) Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
GB9323403D0 (en) Pharmaceuticals
ZA944281B (en) Use of efaroxan and its derivatives for the preparation of a medicinal product intented for the treatment of parkinson's disease
AU1494395A (en) The use of deoxyspergualin for preparing a pharmaceutical for treating hyperreactive inflammatory diseases
MX9709438A (es) Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.
MX9704336A (es) Uso de agentes antivirales para el tratamiento y profilaxis de infecciones latentes de herpesvirus.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110305